Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY‑2 mechanisms substudies - Williams, B; MacDonald, T M; Morant, S V (Lancet Diabetes Endocrinol, 2018)
. doi:10.1016/S2213-8587(18)30071-8